SCHEMBL6949088

SCHEMBL6949088

O=C(NCc1ccccc1F)C1CC2CCC(C1)N2

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.54
KDM4E B2RXH2 2/20 0.51
LMNA P02545 1/20 0.50
ALDH1A1 P00352 2/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
NPC1 O15118 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5072892 0.84 PKM (0.66) PKMKDM4ELMNAALDH1A1POLB
SCHEMBL13745755 0.81 PKM (0.59) PKMKDM4ELMNAALDH1A1POLB
Formic Acid SCHEMBL5082474 0.79 PKM (0.60) PKMKDM4ELMNAALDH1A1POLB
SCHEMBL5364591 0.77 TDP1 (0.62) PKMKDM4ELMNAALDH1A1POLB
SCHEMBL6941883 0.73 KDM4E (0.52) PKMKDM4ELMNAALDH1A1POLB
SCHEMBL25230284 0.73 KMT2A (0.48) PKMKDM4ELMNAALDH1A1RXFP1
SCHEMBL12741415 0.72 OPRL1 (0.53) PKM
SCHEMBL3518823 0.71 SIGMAR1 (0.38) LMNAALDH1A1
SCHEMBL24424324 0.71 POLB (0.56) POLBMAPTRXFP1KMT2A
SCHEMBL24422923 0.71 POLB (0.56) POLBMAPTRXFP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP disclosed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP disclosed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US disclosed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed